University of California, San Francisco
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, San Francisco sits in the top decile of US sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count).
University of California, San Francisco: 1,713 sponsored US clinical trials, 272 recruiting.
University of California, San Francisco sponsors 1,713 registered US clinical trials on ClinicalTrials.gov, 272 of them currently recruiting, and 1,130 completed. 196 of these trials are in Phase 3-4 (later-stage) and 359 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 18 trials.
Top-decile sponsor footprint
University of California, San Francisco ranks in the top decile of sponsors by registered trial count (#10 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
1,130 of 1,305 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (86.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,713 total, page 7 of 35
Predicting Cognitive Decline From Androgen Deprivation Therapy
NCT05820932
Evaluating a Low-Cost Therapeutic Device in Managing Head and Neck Cancer Patients With Radiation-Related Trismus
NCT05671861
Multiple Sclerosis Falls Insight Track
NCT05837949
Wearables for the Bladder: an In-home Treatment Feasibility Pilot Study
NCT05715268
Neural Mechanisms of Meditation Training in Healthy and Depressed Adolescents: An MRI Connectome Study PART 2
NCT05267340
Restoring Metabolic and Reproductive Health With Sleep in PCOS Study, CPAP Trial
NCT05920694
Perinatal Research on Improving Sleep and Mental Health
NCT05596318
Neonatal Seizure Registry, GEnetics of Post-Neonatal Epilepsy
NCT05361070
Assessing Brain Metabolism Using MRS With Deuterated Glucose
NCT06594315
Angiotensin II in Liver Transplantation
NCT04901169
Comparing the Effects of Psilocin and Psilocybin in Healthy Adults
NCT05317689
Simultaneously Implementing Pathways for Improving Asthma, Pneumonia, and Bronchiolitis Care for Hospitalized Children
NCT05206695
Transcranial Magnetic Stimulation for Chronic Neuropathic Pain
NCT05593237
SKY Breath Intervention
NCT05388110
Collaborative Approach to Examining Adversity and Building Resilience Study
NCT05259436
Pilot Test of Apnea and Insomnia Relief for Veterans With Gulf War Illness
NCT05137743
Kebele Elimination of Trachoma for Ocular Health
NCT03335072
Coronavirus Disease 2019 (Covid-19) Impact on Alcohol-related Liver Disease Patient Outcomes, Care and Alcohol Use
NCT05191446
Psilocybin Therapy for Depression in Bipolar II Disorder
NCT05065294
Development and Feasibility of Mindfulness Based Pain Reduction
NCT04980612
Watermelon/UBIQuinone Study
NCT04972552
Infant Mortality Reduction by the Mass Administration of Azithromycin
NCT04716712
Prevalence and Predictors of Hepatic Steatosis in Persons Living With HIV
NCT04795219
Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Precision Medicine Phase 2 Option 1
NCT04602806
Social & Contextual Impact on Children Undergoing Liver Transplantation
NCT04551742
Impact of Ocrelizumab on Cerebrospinal Fluid Biomarkers at Multiple Sclerosis Onset
NCT04466150
Combinatorial Therapy to Induce an HIV Remission
NCT04357821
A Neuroimaging Study of Open-label Placebo in Depressed Adolescents
NCT04201106
Assessing the Safety of Pregnancy In the CoRonavirus (COVID-19) pandEmic
NCT04388605
The Role of Cerebellum in Speech
NCT03972202
BGB-290 and Temozolomide in Treating Isocitrate Dehydrogenase (IDH)1/2-Mutant Grade I-IV Gliomas
NCT03749187
Attitudes and Decision-making After Pregnancy Testing Study
NCT03888404
Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
NCT03739372
Hydrops: Diagnosing & Redefining Outcomes With Precision Study
NCT03412760
The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy
NCT03582891
Osimertinib in Treating Participants With Stage I-IIIA EGFR-mutant Non-small Cell Lung Cancer Before Surgery
NCT03433469
Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II)
NCT03999151
Developmental Epidemiological Study of Children Born Through Reproductive Technology
NCT03799107
Hand Rehabilitation Study for Stroke Patients
NCT03148106
Secondhand Smoke Respiratory Health Study
NCT02797275
PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer
NCT02735252
Innate Immunity in Ozone-induced Airway Inflammation in COPD
NCT04669743
Immediate Initiation of Antiretroviral Therapy During "Hyperacute" HIV Infection
NCT02656511
PCOS & Insulin Resistance Exercise Study
NCT02303470
Behavioral Research of Environment and Air Pollution Through Education
NCT02471872
Uterine Leiomyoma Treatment With Radiofrequency Ablation (ULTRA) Registry
NCT02100904
Intraoperative Radiation Therapy in Treating Patients With Breast Cancer Undergoing Breast-Conserving Surgery
NCT01570998
Effects of Brain Beta-Amyloid on Postoperative Cognition
NCT01606488
Mediators of Atherosclerosis in South Asians Living in America
NCT01207167
Modifiers of Disease Severity in Cerebral Cavernous Malformations
NCT01764529
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 193 |
| Phase 2 | 166 |
| Phase 3 | 44 |
| Phase 4 | 152 |
Therapeutic Areas
What is open in the University of California, San Francisco pipeline
272 recruiting of 1,713 indexed (16% open); 1,130 completed (66%).
Phase mix: 196 late (III/IV) vs 359 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (18 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, San Francisco: open-pipeline peers nationwide
Peers matched on 1,713 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
University of California, San Francisco sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,713 trials (± recruiting share)
- Duke University · 1,725 trials · 11% recruiting
- Stanford University · 1,744 trials · 15% recruiting
- VA Office of Research and Development · 1,668 trials · 17% recruiting
- Pfizer · 1,845 trials · 6% recruiting
Sponsors near 16% open enrollment (± trial volume)
- University of Oregon · 16% recruiting · 63 trials
- Fox Chase Cancer Center · 16% recruiting · 183 trials
- Youngstown State University · 16% recruiting · 19 trials
- ECOG-ACRIN Cancer Research Group · 16% recruiting · 75 trials
Related
What to do with this University of California, San Francisco page
1,713 registered trials is a research-attention snapshot, not an endorsement of University of California, San Francisco or any single study.
- 272 of University of California, San Francisco's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition University of California, San Francisco studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of California, San Francisco pipeline card: 1,713 registered trials from official public datasets.Report a data error.